Secondino S, Carrabba MG, Pedrazzoli P, Castagna L, Spina F, Grosso F, Bertuzzi A, Bay JO, Siena S, Corradini P, Niederwieser D, Demirer T; European Group for Blood and Marrow Transplantation Solid Tumors Working Party. Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation. Haematologica. 2007 Mar;92(3):418-20. PMID: 17339195 [PubMed - indexed for MEDLINE]

Barkholt L, Bregni M, Remberger M, Blaise D, Peccatori J, Massenkeil G, Pedrazzoli P, Zambelli A, Bay JO, Francois S, Martino R, Bengala C, Brune M, Lenhoff S, Porcellini A, Falda M, Siena S, Demirer T, Niederwieser D, Ringden O; French ITAC group and the EBMT Solid Tumour Working Party. Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. Ann Oncol. 2006 Jul;17(7):1134-40. Epub 2006 Apr 28. PMID: 16648196 [PubMed - indexed for MEDLINE]

Pedrazzoli P, Ledermann JA, Lotz JP, Leyvraz S, Aglietta M, Rosti G, Champion KM, Secondino S, Selle F, Ketterer N, Grignani G, Siena S, Demirer T; European Group for Blood and Marrow Transplantation (EBMT) Solid Tumors Working Party. High dose chemotherapy with autologous hematopoietic stem cell support for solid tumours other than breast cancer in adults. Ann Oncol. 2006 Oct;17(10):1479-88. Epub 2006 Mar 17. PMID: 16547069 [PubMed - in process]

Bregni M, Ueno NT, Childs R. The second international meeting on allogeneic transplantation in solid tumors. Bone Marrow Transplant. 2006 Oct;38(8):527-37. Epub 2006 Sep 4. PMID: 16953213 [PubMed - indexed for MEDLINE]

Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H, Gratwohl A, Madrigal A, Niederwieser D, Passweg J, Rocha V, Saccardi R, Schouten H, Schmitz N, Socie G, Sureda A, Apperley J; European Group for Blood and Marrow. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant. 2006 Mar;37(5):439-49. PMID: 16444286 [PubMed - indexed for MEDLINE]

Peccatori J, Barkholt L, Demirer T, Sormani MP, Bruzzi P, Ciceri F, Zambelli A, Da Prada GA, Pedrazzoli P, Siena S, Massenkeil G, Martino R, Lenhoff S, Corradini P, Rosti G, Ringden O, Bregni M, Niederwieser D; The European Bone Marrow Transplantation Solid Tumor Working Party. Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation. Cancer. 2005 Nov 15;104(10):2099-103. PMID: 16220555 [PubMed - indexed for MEDLINE]

De Giorgi U, Rosti G, Slavin S, Yaniv I, Harousseau JL, Ladenstein R, Demirer T, Dini G; on the behalf of the European Group for Blood and Marrow Transplantation Solid Tumours and Paediatric Disease Working Parties. Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours. Br J Cancer. 2005 Aug 22;93(4):412-7.

Bengala C, Guarneri V, Ledermann J, Rosti G, Wandt H, Lotz JP, Cure JH, Orlandini C, Ferrante P, Conte PF, Demirer T; EBMT Solid Tumor Working Party. High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2005 Jul;36(1):25-31

Giorgi U De, Demirer T, Wandt H, Taverna C, Siegert W, Bornhauser M, Kozak T, Papiani G, Ballardini M, Rosti G. Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary nonseminomatous germ cell tumors: the EBMT experience. Ann Oncol. 2005 Jan;16(1):146-51

Giorgi U D, Wandt H, Lioure B, Leyvraz S, Papiani G, Ballardini M, Kulekci A, Demirer T. First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors. The experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working party. Bone Marrow Transplantation, Dec;34 (12): 1033-1037, 2004

Gratwohl A, Baldomero H, Demirer T et all. HSCT for solid tumors in Europe. Annals of Oncology. 2004; Apr;15(4):543-4.

P. Pedrazzoli, P. Ferrante, A. Kulekci, R. Schiavo, U De Giorgi, O Carminati, M. Marangolo, T. Demirer, S. Siena, G. Rosti. Autologous hematopoitic stem cell transplantation for breast cancer in Europe: Critical evaluation of data from the EBMT registry 1990-1999. Bone Marrow Transplant. 2003 Sep;32(5):489-94

N. Kröger, A. R. Zander, G. Martinelli, P. Ferrante, JM. Moraleda, T. Demirer, G. Socie, G. Rosti. Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation. Annals of Oncology. 2003 Apr;14(4):554-8

De Giorgi U;Rosti G;Papiani G;Marangolo M; The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients. Haematologica. 2002 Jan;87(1):95-104.

Rosti G;Ferrante P;Ledermann J;Leyvraz S;Ladenstein R;Koscileniak E;Crown J;Dazzi C;Cariello A;Marangolo M; High-dose chemotherapy for solid tumors: results of the EBMT. Crit Rev Oncol Hematol. 2002 Feb;41(2):129-40

Ledermann JA;Herd R;Maraninchi D;Viens P;Buclon M;Philip T;Cure H;Lotz JP;Chauvin F;Ferrante P;Rosti G; High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT). Ann Oncol. 2001; 12:693-699

Ledermann JA; High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer. Int J Gynecol Cancer. 2000; 10:53-56

Ledermann JA. Long-term results of high-dose chemotherapy for ovarian cancer. An analysis from the solid tumors registry of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2000; 26 (S1): S20.

Castagna L, Pico JL, Rosti G. High-dose chemotherapy in ovarian germ cell tumors (GCT) : a survey of the European Group for Blood and Marrow Transplantation Solid Tumors Working party (EBMT-STWP). Bone Marrow Transplant 2000; 26 (S1): S25-S26.

Wandt H, Schaefer-Eckart K, Denzel T, Birkmann J, Gallmeier W. Results of the Nurnberg phase II study and presentation of the EBMT OVCAT randomized study. Bone Marrow Transplant 2000; 26 (S1): S23-S24.

Rosti G, Ferrante P, Crown J, Marangolo M et al. The EBMT Registry update: breast cancer. Bone Marrow Transplant 2000; 26 (S1): S2-S4.

Gratwohl A, Baldomero H, Rosti G. High-dose chemotherapy for breast cancer. Bone Marrow Transplant 2000; 26: 599-600.

Neymark N, Rosti G. Patient management strategies and transplantation techniques in European stem cell transplantation centers offering breast cancer patients high-dose chemotherapy peripheral blood stem cell support: a joint report from the EORTC and EBMT. Haematologica 2000; 85: 733-744.

Rosti G, Ferrante P, Marangolo M et al on behalf of the EBMT STWP. High-dose chemotherapy for breast cancer in Europe. from fashion to randomization. In: Abraham NG, Tabilio A, Martelli M, Asano T, Donfrancesco A (eds). Molecular Biology of Hematopoiesis 6. Kluwer Academic: New York,1999, pp 141-146.

Leyvraz S, Perey L, Rosti G et al. Multiple courses of high-dose ifosfamide, carboplatin and etoposide with peripheral blood progenitor cells and filgrastim for small cell lung cancer: a feasibility study by the European Group for Blood and Marrow Transplantation. J Clin Oncol 1999; 17: 3531-3539.

Ledermann JA, Herd R, Maraninchi D et al. High-dose chemotherapy in ovarian cancer : an analysis of the experience of the European Group for Blood and Marrow Transplantation (EBMT) over 7 years. Proc ASCO 18; 360a (abstract), 1999.

Koscelniak E, Rosti G, Hartmann O et al. 20 years experience with high-dose chemotherapy (HDC) in patients with metastatic and recurrent rhabdomyosarcoma (RMS). An EBMT Solid Tumors Working Party update 1998. Bone Marrow Transplant 23 (S1): S632 (abstract), 1999.

Ladenstein R, Hartmann O, Pinkerton R et al. A mutivariate and paired matched analysis on high-risk Ewing Tumor (ET) patients treated by megatherapy (MGT) and stem cell reinfusion (SCR) in Europe. Proc ASCO:18: 555a (abstract), 1999.

Rosti G, Ferrante P. High-dose chemotherapy (HDCT) as adjuvant therapy for patients with >20 positive axillary nodes: an EBMT registry retrospective analysis. Bone Marrow Transplant 1999; 23(S1) : S133 (abstract).

Neymark N, Rosti G. Peripheral blood stem cell transplantation for breast carcinoma in Europe 1998: a joint EBMT and EORTC report. Proc ASCO 18: 64ª (abstract), 1999.

Leyvraz S, Perey L, Rosti G, Lange A, Pampallona S, Peters R, Humblet Y, Bosquée L, Pasini F, Marangolo M. Multiple courses of High-dose Ifosfamide, Carboplatin and Etoposide with Peripheral Blood Progenitor Cells and Filgrastim for Small Cell Lung Cancer: a Feasibility Study by the European Group for Blood and Marrow Transplantation. J Clin Oncol 1999; 17: 3531-3539.

Ladenstein R, Philip T, Lasset C, Hartmann O, Garaventa A, Pinkerton R, Michon J, Pritchard J, Klingebiel T, Kremens B, Pearson A, Coze C, Paolucci P, Frappaz D, Gadner H, Chauvin F. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumour Registry. J Clin Oncol 1998; 16: 953-965.

Rosti G, Ferrante P, Pico JL et al. Ongoing studies and the EBMT Database. ESO Scientific Updates, Vol. 3, Rosti G, Ed., Elsevier Publ, 1998, pp 83-97.

Perey L, Rosti G, Lange A, Bosquée, Pasini F, Humblet Y, Hamdan O, Pampallona S, Leyvraz S. Final results of the EBMT study of sequential high-dose ICE with circulating progenitor cells CPC in small cell lung cancer SCLC. Bone Marrow Transplant 1998; 22 (Suppl 3): S111-S113.

Wandt H, Brikmann J, Schaefer-Eckart K, Denzel T, Both A, Egger H, Gallmeier WM. Long-term follow-up of 21 patients after sequential high-dose chemotherapy as basis for the randomized EBMT study in ovarian cancer. Bone Marrow Transplant 1998; 22 (Suppl. 3): 111-114.

Koscielniak E, Truener J, Rosti G, Philip T. Prognosis in chilen with metastatic and recurrent soft tissue sarcoma. Do they benefit from high-dose therapy? Bone Marrow Transplant 1998; 22 (Suppl 3): S75-S77.

Rosti G, Ferrante P, Marangolo M. High-dose chemotherapy in breast cancer in Europe in 1996. Proceedings of the Eighth International Symposium in Arlington Texas. In: Dicke KA and Keating A, Carden Jennings Publ. Co. pp. 259-265, 1997.

Philip T, et al. 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. Eur J Cancer 1997; 33 (Suppl. 12): 2130-2135.

Rossetti F, Rondelli R, Dini G, Meloni G, Messina C, Miniero R, Locatelli F, Andolina M, Pession A, Amici A, Favre C, Porta F, Uderzo C, Di Bartolomeo P, Donfrancesco A, Paolucci P. Pediatric autologous BMT in Italy: 10 years experience. In: Dicke KA and Keating A, eds pp. 607-612, 1995.

Rosti G, Gianni AM, Albertazzi L, Marangolo M, Bjrökstrand B, Gisselbrecht C, Zander AR, Coombes RC, Rodenhuis S, Efremedis A, Conde JG Ptushkin VV, Philip T. High-dose chemotherapy programs for breast cancer in Europe. In: Dicke KA, and Keating A (eds). pp. 207-210, 1995.

Biron P, oz JP. High-dose chemotherapy and hematopoietic stem cell support in germ cell tumours. European experience. In: Dicke KA, and Keating A, eds pp 437-438, 1995.

Pinkerton R. Chemiotherapie massive suivie d'autograffe de moelle en oncologie pediatrique: les arguments contre. Bull. Cancer 1995; 82: 42-45.

Hartmann O, Valteau-Couanet D, Benhamon E. Chemiotherapie a haute dosis suivie d'autograffe de moelle dous les tumours solidies de l'enfant: les arguments Bull Cancer 1995; 82: 36-41.

Philip T. Chemiotherapie massive suivie d'autograffe de moelle en oncologie pediatrique: pour ou contre. Editorial. Bull Cancer 1995; 82: 3-5.

Ladenstein R, Lasset C, Hartmann O, Klingebiel T, Bouffet E, Gadner H, Paolucci A, Burdach S, Chauvin F, Pinkerton R, Philip T. Comparison of auto versus allografts as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 1994; 14: 37-46.

Garaventa A, Hartmann O, Bernard JL, Zucker JM, Pardo N, Castel V, Dallorso S, Abdelbost Z, Ladenstein R, Chauvin F, Philip T. Autologous bone marrow transplantation for pediatric wilms tumor: the experience of the European Bone Marrow Transplantation Solid Tumor Registry. Med Ped Oncol 1994; 22: 11-14.

Ladenstein R, Lasset C, Hartmann O, Frappaz D, Garaventa A, Klingebiel T, Zucker JM, Coze C, Burdach S, Gadner H, Paolucci P, Pearson ADJ Pinkerton R, Chauvin F, Philip T. Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation. J Clini Oncol 1993; 11: 2330-2341.

Ladenstein R, Favrot MC, Lasset C, Bouffet E, Philip I, Combaret V, Chauvin F, Brunat-Mentigny M, Biron P, Philip T. Indication and limits of megatherapy and BMT in high-risk neuroblastoma. A single center analysis of prognostic factors Eur J Cancer 1993; 29 A: 947-956.

Ladenstein R, Lasset C, Hartmann O, Garaventa A, Philip T, for the European Bone Marrow Transplantation Group. High-dose consolidation chemotherapy in infants with stage 4 neuroblastoma. Eur J Cancer 1993; 29 (A), 11:1632 (letter).

Philip T, Ladenstein R, Zucker JM, Pinkerton R, Bouffet E, Louis D, Siegert W, Bernard JL, Frappaz D, Coze C, Wyss M, Beck D, Soulliet G, Michon J, Philip I, Chauvin F, Favrot M, Biron P. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE 2 study. Br J Cancer 1993; 67: 119-127.

Ladenstein R, Hartmann O, Pinkerton CR. The role of megatherapy with autologous bone marrow rescue in solid tumours of childhood. Ann Oncol 1993; 4 (Suppl. 1): 45-58.

Garaventa A, Ladenstein R, Chauvin F, Lanino E, Philip I, Corciulo P, Brisigotti M, Favrot MC, Dini G, Philip T. High dose chemotherapy with autologous bone marrow rescue in advanced stage IV neuroblastoma. Eur J Cancer 1993; 4: 487-491.

Ladenstein R, Lasset C, Philip T. Treatment duration before bone marrow transplantation in stage IV neuroblastoma. Lancet 1992; 340: 916-917 (letter).

Ladenstein R, and Philip T. Megatherapy and immunotherapy in paediatric solid tumours: Paediatric Oncology - Clinical practice and controversies. Eds. Plowman PN and CR Pinkerton, Chapman & Hall Medical London 1st Ed. pp 460-494 1992.

Publications in press (last updated 25.08.05)

Peccatori J, Barkholt L, Demirer T, Sormani M.P, Bruzzi P, Ciceri F, Zambelli A, Da Prada GA, Pedrazzoli P, Siena S, Massenkeil G, Martino R, Lenhoff S, Corradini P, Rosti G, Ringden O, Bregni M and Niederwieser D, on behalf of EBMT Solid Tumor Working Party. Prognostic factors for survival in patients with advanced renal cell cancer undergoing non-myeloablative allogeneic stem cell transplantation. Accepted in CANCER JOURNAL.

Barkholt L, Bregni M, Remberger M, Blaise D, Peccatori J, Massenkiel G, Pedrazzoli P, Zambelli A, Bay J. O, Francois S, Martino R, Bengala C, Brune M, Lenhoff S, Porcellini A, Falda M, Siena S, Demirer T, Niederwieser D and Ringdén O. On behalf of the EBMT Solid Tumour Working Party. European experience of allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma. Submitted.

Bengala C, Guarneri V, Ledermann J, Rosti G, Wandt H, Lotz JP, Cure JH, Orlandini C, Ferrante P, Conte PF, Demirer T on behalf of EBMT Solid Tumor Working Party. High-dose chemotherapy with autologous hemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumor Registry of the European Group for Blood and marrow Transplantation (EBMT). In press BONE MARROW TRANSPLANT.

Giorgi U De, Rosti G, Slavin S, Yaniv I, Harousseau JL, Ladenstein R, Demirer T, Dini G. Salvage high-dose chemotherapy for children with extragonadal germ cell tumours. In press BRITISH JOURNAL of CANCER.

EBMT News Updates (click on the pdf symbol)

November 2003